DAVID NEWCOMB HERNDON, M.D.
Radiology at Market St, Galveston, TX
License number
Texas G1675
Category
Radiology
Type
Surgery
Address
Address
815 Market St, Galveston, TX 77550
Phone
(409) 770-6731
(409) 770-6919 (Fax)
(409) 770-6919 (Fax)
Personal information
See more information about DAVID NEWCOMB HERNDON at radaris.comName
Address
Phone
6523 Fawnwood Dr, Spring, TX 77389
4807 Palo Duro Ln, Dallas, TX 75216
400 Southview Trl, Southlake, TX 76092
4043 Happy Canyon Dr, Dallas, TX 75241
4512A Maxie St, Houston, TX 77007
Professional information
Dr. David N Herndon, Galveston TX - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery
Address:
UTMB Health General Surgery
301 University Blvd, Galveston 77555
(409) 772-2222 (Phone)
301 University Blvd, Galveston 77555
(409) 772-2222 (Phone)
Certifications:
Critical Care Surgery, 2008, General Surgery, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UTMB Health General Surgery
301 University Blvd, Galveston 77555
University of Texas Medical Branch Galveston
301 University Blvd, Galveston 77555
301 University Blvd, Galveston 77555
University of Texas Medical Branch Galveston
301 University Blvd, Galveston 77555
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1974
University Hospitals Of Cleveland
Duke University Hospital
New York Hospital
Inst Surg Rsch
Case Western Reserve University School of Medicine
Graduated: 1974
University Hospitals Of Cleveland
Duke University Hospital
New York Hospital
Inst Surg Rsch
David Newcomb Herndon, Galveston TX
Specialties:
Surgeon
Address:
301 University Blvd, Galveston, TX 77555
815 Market St, Galveston, TX 77550
815 Market St, Galveston, TX 77550
Education:
Case Western Reserve University, School of Medicine - Doctor of Medicine
Brooke Army Medical Center - Fellowship - Surgical Research
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Surgery
Brooke Army Medical Center - Fellowship - Surgical Research
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery, American Board of Surgery Sub-certificate in Surgical Critical Care (Surgery)
David Newcomb Herndon, Galveston TX
Specialties:
Surgery, Surgical Critical Care, Trauma Surgery
Work:
The University of Texas at Galveston
301 University Blvd, Galveston, TX 77555 Shriners Hospitals for Children - Galveston Burns Hospital
815 Market St, Galveston, TX 77555
301 University Blvd, Galveston, TX 77555 Shriners Hospitals for Children - Galveston Burns Hospital
815 Market St, Galveston, TX 77555
Education:
Case Western Reserve University(1974)
Methods To Enhance Wound Healing And Enhanced Wound Coverage Material
US Patent:
6576618, Jun 10, 2003
Filed:
Jun 22, 2000
Appl. No.:
09/602183
Inventors:
David N. Herndon - Galveston TX
Jose R. Perez-Polo - Galveston TX
Robert E. Barrow - Galveston TX
Jose R. Perez-Polo - Galveston TX
Robert E. Barrow - Galveston TX
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 91127
US Classification:
514 44, 4353201, 435455, 435458, 424450
Abstract:
The present invention describes the incorporation of liposomal gene constructs directly into a wound to further improve wound repair, or into wound coverage and/or closure materials to enhance the functionality of the material. The present invention further describes the use of human fetal membranes (e. g. , amnion) enhanced with the liposomal gene therapy as a wound coverage material in full-thickness wound repair. The enhanced fetal membranes or enhanced cadaver skin have advantages over currently used materials lacking the liposomal gene construct and are an efficient and safe approach to improve clinical outcome in patients with burn injuries.
Methods To Enhance Wound Healing And Enhanced Wound Coverage Material
US Patent:
2002012, Sep 12, 2002
Filed:
Dec 19, 2001
Appl. No.:
10/025274
Inventors:
David Herndon - Galveston TX, US
Jose Perez-Polo - Galyeston TX, US
Robert Barrow - Galveston TX, US
Jose Perez-Polo - Galyeston TX, US
Robert Barrow - Galveston TX, US
Assignee:
Research Development Foundation
International Classification:
A61K048/00, A61K009/127
US Classification:
514/044000, 424/450000
Abstract:
The present invention describes the incorporation of liposomal gene constructs directly into a wound to further improve wound repair, or into wound coverage and/or closure materials to enhance the functionality of the material. The present invention further describes the use of human fetal membranes (e.g., amnion) enhanced with the liposomal gene therapy as a wound coverage material in full-thickness wound repair. The enhanced fetal membranes or enhanced cadaver skin have advantages over currently used materials lacking the liposomal gene construct and are an efficient and safe approach to improve clinical outcome in patients with burn injuries.
Beta-Adrenergic Blockade Reversal Of Catabolism After Severe Burn
US Patent:
7098248, Aug 29, 2006
Filed:
Jul 9, 2001
Appl. No.:
09/901429
Inventors:
David S. Herndon - Galveston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 31/135
US Classification:
514651, 424810, 530350
Abstract:
Provided herein is a method of method of treating an individual having a severe burn, comprising the step of administering to said individual a pharmacologically effective dose of a beta-adrenergic antagonist.
Treatment Of Lung Disorders
US Patent:
2004019, Sep 30, 2004
Filed:
Mar 25, 2003
Appl. No.:
10/396855
Inventors:
Kazunori Murakami - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Lillian D. Traber - Galveston TX, US
Donald S. Prough - Galveston TX, US
David N. Herndon - Galveston TX, US
Daniel L. Traber - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Lillian D. Traber - Galveston TX, US
Donald S. Prough - Galveston TX, US
David N. Herndon - Galveston TX, US
Daniel L. Traber - Galveston TX, US
International Classification:
A61K038/48
US Classification:
514/012000
Abstract:
The invention features methods of treating a subject having a lung disorder such as lung inflammation and injury, by administering antithrombin III by inhalation.